Scientists analyzed over 77,000 genome sequences of SARS-CoV-2 and identified over 15,000 mutations, including nearly 15,000 single nucleotide polymorphisms. One notable mutation was the alteration of aspartic acid to glycine at position 614 of the spike protein (D614G), which has become the dominant global form and may increase infectivity. While studies using pseudoviruses suggest this mutation increases viral loads and infectious titers, its effects on natural infection and transmissibility require validation through experiments with live virus in cell and animal models.
Scientists analyzed over 77,000 genome sequences of SARS-CoV-2 and identified over 15,000 mutations, including nearly 15,000 single nucleotide polymorphisms. One notable mutation was the alteration of aspartic acid to glycine at position 614 of the spike protein (D614G), which has become the dominant global form and may increase infectivity. While studies using pseudoviruses suggest this mutation increases viral loads and infectious titers, its effects on natural infection and transmissibility require validation through experiments with live virus in cell and animal models.
Scientists analyzed over 77,000 genome sequences of SARS-CoV-2 and identified over 15,000 mutations, including nearly 15,000 single nucleotide polymorphisms. One notable mutation was the alteration of aspartic acid to glycine at position 614 of the spike protein (D614G), which has become the dominant global form and may increase infectivity. While studies using pseudoviruses suggest this mutation increases viral loads and infectious titers, its effects on natural infection and transmissibility require validation through experiments with live virus in cell and animal models.
To assess the genetic variation of different SARS-
CoV-2 strains, the 2019 Novel Coronavirus Resource
of China National Center for Bioinformation aligned 77,801 genome sequences of SARS-CoV-2 detected glob- ally and identified a total of 15,018 mutations, including 14,824 single-nucleotide polymorphisms (BIGD)31. In the S protein, four amino acid alterations, V483A, L4551, F456V and G476S, are located near the binding interface int the RBD, but their effects on binding to the host receptor are unknown. The alteration D614G in the S1 subunit was found far more frequently than other S variant sites, and it is the marker of a major subclade of SARS-CoV-2 (clade G). Since March 2020, SARS-CoV-2 variants with G614 in the S protein have replaced the original D614 variants an become the dominant form circulating globally. Compared with the D614 variant, higher viral loads were found in patiens infected with the G614 variant, but clinical data suggested no signif- icant link between the D614 alteration and deseas severity32. Pseudotyped viruses carrying the S protein with G614 generated higher infectious titres than virus carrying the S protein wit D614, suggesting the altera- tion may have increased the invectivity of SARS-CoV-2 (REF.32). However, the results of in vitro experiments based on pseudovirus models may not exactly reflect natural infection. This preliminary finding should be validated by more studies using wild-type SARS-CoV-2 variants to infect different target cells and animal models. Whether this amino acis change anchanced virus transmissibil- ity is also to be determined. Another marker mutation for SARS-CoV-2 evolution is the single-nucleotide